DESCRIPTION
Ranitidine HCl is a histamine
H2-receptor antagonist. Chemically it is N[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N¢-methyl-2
-nitro-1,1-ethenediamine, hydrochloride.
The empirical formula
is C13H22N4O3S·HCl,
representing a molecular weight
of 350.87.
Ranitidine HCl is a white to
pale yellow, granular substance
that is soluble in water. It has a slightly bitter
taste and sulfurlike odor.
Oral
Each Zantac 150 tablet for
oral administration
contains 168 mg of ranitidine HCl equivalent
to 150 mg of ranitidine. Each tablet
also contains the inactive ingredients FD&C yellow
No. 6 aluminum lake, hydroxypropyl
methylcellulose, magnesium stearate, microcrystalline
cellulose, titanium dioxide,
triacetin, and yellow iron
oxide.
Each Zantac 300 tablet for
oral administration
contains 336 mg of ranitidine HCl equivalent
to 300 mg of ranitidine. Each tablet
also contains the inactive ingredients croscarmellose sodium, D&C
yellow No. 10 aluminum
lake, hydroxypropyl methylcellulose, magnesium
stearate, microcrystalline
cellulose, titanium dioxide, and triacetin.
Zantac 150 geldose capsules and Zantac 300 geldose capsules for oral
administration are soft gelatin
capsules containing 168 mg of ranitidine HCl equivalent
to 150 mg of ranitidine and 336 mg of ranitidine HCl equivalent to 300
mg of ranitidine, respectively, in a nonaqueous matrix
of synthetic coconut oil and synthetic
triglycerides. The soft gelatin
capsule shell contains gelatin,
sorbitol special (sorbitol
and sorbitol anhydrides),
glycerin, purified water, titanium
dioxide, FD&C yellow No.
6, FD&C blue No. 1, and FD&C red
No. 40. The capsule shell
may also contain mineral oil and
soybean lecithin. The capsules are printed with edible ink.
Zantac 150 EFFERdose tablets and Zantac 150 EFFERdose granules for oral
administration are effervescent
formulations of ranitidine that must be dissolved in water
before use. Each individual tablet
or the contents of a packet contain 168 mg of ranitidine HCl equivalent
to 150 mg of ranitidine and the following inactive ingredients: aspartame,
monosodium citrate anhydrous,
povidone, and sodium bicarbonate.
Each tablet also contains sodium
benzoate. The total sodium
content of each tablet is 183.12
mg (7.96 mEq) per 150 mg of ranitidine,
and the total sodium content
of each packet of granules is 173.54 mg (7.55 mEq) per
150 mg of ranitidine.
Each 1 ml of Zantac syrup
contains 16.8 mg of ranitidine HCl equivalent to 15 mg of ranitidine.
Zantac syrup also contains the
inactive ingredients alcohol (7.5%), butylparaben, dibasic
sodium phosphate, hydroxypropyl
methylcellulose, peppermint flavor, monobasic
potassium phosphate, propylparaben,
purified water, saccharin
sodium, sodium chloride, and
sorbitol.
Injection, Injection Premixed, and Injection Pharmacy Bulk Package¾Not
for Direct Infusion
Ranitidine HCl Injection is a clear, colorless to yellow, nonpyrogenic
liquid. The yellow color
of the liquid tends to intensify
without adversely affecting potency. The pH
of the injection solution
is 6.7 to 7.3.
Sterile Injection for Intramuscular or Intravenous Administration
or Injection Pharmacy Bulk Package: Each 1 ml
of aqueous solution contains
ranitidine 25 mg (as the hydrochloride); phenol
5 mg as preservative; and 0.96 mg of monobasic
potassium phosphate
and 2.4 mg of dibasic sodium
phosphate as buffers.
Injection Pharmacy Bulk Package¾Not
for Direct Infusion: A pharmacy bulk
package is a container of
a sterile preparation
for parenteral use that
contains many single doses. The contents are intended for use in a pharmacy
admixture program and are
restricted to the preparation
of admixtures for intravenous
(IV) infusion.
Sterile, Premixed Solution for Intravenous Administration in Single-Dose,
Flexible Plastic Containers: Each 50 ml
contains ranitidine HCl equivalent to 50 mg of ranitidine, sodium
chloride 225 mg, and citric
acid 15 mg and dibasic sodium
phosphate 90 mg as buffers
in water for injection. It contains
no preservatives. The osmolarity of this solution
is 180 mOsm/l (approx.), and the pH
is 6.7 to 7.3.
The flexible plastic container
is fabricated from a specially formulated, nonplasticized, thermoplastic
co-polyester (CR3). Water can permeate from inside the container
into the overwrap but not in amounts sufficient to affect the solution
significantly. Solutions inside the plastic
container also can leach out certain of the chemical
components in very small amounts before the expiration
period is attained. However,
the safety of the plastic has been confirmed by tests in animals according
to USP biological standards
for plastic containers.
CATEGORIES, BRAND NAMES
CATEGORIES: Acid/peptic disorder; Esophagitis, erosive;
Hypersecretion, gastrointestinal; Mastocytosis; Reflux, gastroesophageal;
Ulcer, peptic; Zollinger-Ellison syndrome; Pregnancy Category B; FDA Approved
1983 Jun; Top 200 Drugs
FDA Drug Classes: Antihistamines; Acid/Peptic Disorders
BRAND NAMES:
BRAND NAMES: Achedos; Acidex; Aciloc;
Acloral; Aldin; Anistal; Antagonin; Apo-Ranitidine;
Apozan; Atural; Axoban; Azantac; Consec;
Coralen; Curan; Eltidine; Ezopta; Galidrin;
Gastrial; Gastridin; Gastrosedol; Histac;
Histak; Lydin; Microtid; Neoceptin-R; Ptinolin;
Quantor; Quicran; Radinat; Ranacid; Randin;
Rani 2; Ranial; Raniben; Ranidil; Ranidine;
Ranimex; Ranin; Raniogas; Raniplex; Ranisen;
Ranital; Ranitiget; Ranix; Rantac; Rantacid;
Rantin; Ratic; Raticina; Rosimol; RND;
Simetac; Sostril; Taural; Ul-Pep; Ulceran;
Ulceranin; Ulcex; Ulcirex; Ulsal; Ultac;
Urantac; Verlost; Vesyca; Vizerul; Weichilin;
Weidos; Xanidine; Zantab; Zantac; Zantadin;
Zantic; Zinetac
(Foreign Brand names outside U.S. in italics)
FOREIGN BRAND AVAILABILITY:
Achedos (Peru)
Acidex (Argentina)
Aciloc (India)
Acloral (Mexico)
Aldin (India)
Anistal (Mexico)
Antagonin (Benin; Burkina-Faso; Ethiopia; Gambia; Ghana; Guinea; Ivory-Coast;
Kenya; Liberia; Malawi; Mali; Mauritania; Mauritius; Morocco; Niger; Nigeria;
Senegal; Seychelles; Sierra-Leone; Sudan; Tanzania; Tunia; Uganda; Zambia;
Zimbabwe)
Apo-Ranitidine (Canada; New-Zealand)
Apozan (Israel)
Atural (Peru)
Axoban (Japan)
Azantac (France; Mexico)
Consec (India)
Coralen (Spain)
Curan (Korea)
Eltidine (Korea)
Ezopta (Greece)
Galidrin (Mexico)
Gastrial (Argentina)
Gastridin (Indonesia)
Gastrosedol (Argentina)
Histac (Bahrain; Benin; Burkina-Faso; Cyprus; Egypt; Ethiopia; Gambia;
Ghana; Guinea; India; Iran; Iraq; Ivory-Coast; Jordan; Kenya; Kuwait;
Lebanon; Liberia; Libya; Malawi; Mali; Mauritania; Mauritius; Morocco;
Niger; Nigeria; Oman; Qatar; Republic-of-Yemen; Saudi-Arabia; Senegal;
Seychelles; Sierra-Leone; Sudan; Syria; Tanzania; Thailand; Tunia; Uganda;
United-Arab-Emirates; Zambia; Zimbabwe)
Histak (South-Africa)
Lydin (India)
Microtid (Mexico)
Neoceptin-R (Benin; Burkina-Faso; Ethiopia; Gambia; Ghana; Guinea; Ivory-Coast;
Kenya; Liberia; Malawi; Mali; Mauritania; Mauritius; Morocco; Niger; Nigeria;
Senegal; Seychelles; Sierra-Leone; Sudan; Tanzania; Tunia; Uganda; Zambia;
Zimbabwe)
Ptinolin (Greece)
Quantor (Spain)
Quicran (Taiwan)
Radinat (Ecuador)
Ranacid (Norway)
Randin (Bahrain; Cyprus; Egypt; Iran; Iraq; Jordan; Kuwait; Lebanon; Libya;
Oman; Qatar; Republic-of-Yemen; Saudi-Arabia; Syria; United-Arab-Emirates)
Rani 2 (Australia)
Ranial (India)
Raniben (Italy)
Ranidil (Italy)
Ranidine (Thailand)
Ranimex (Finland)
Ranin (Indonesia)
Raniogas (Colombia)
Raniplex (France)
Ranisen (Mexico)
Ranital (Slovenia)
Ranix (Philippines)
Rantac (India)
Rantacid (Finland)
Rantin (Indonesia)
Ratic (Thailand)
Raticina (Argentina)
Rosimol (Argentina)
RND (Taiwan)
Simetac (Hong-Kong)
Sostril (Germany)
Taural (Argentina; Costa-Rica; Dominican-Republic; Ecuador; El-Salvador;
Guatemala; Honduras; Nicaragua; Panama)
Ul-Pep (Colombia)
Ulceran (Peru)
Ulceranin (Indonesia)
Ulcex (Italy)
Ulcirex (France)
Ulsal (Austria)
Ultac (India)
Urantac (Korea)
Verlost (Greece)
Vesyca (Taiwan)
Vizerul (Argentina)
Weichilin (Taiwan)
Weidos (Taiwan)
Xanidine (Thailand)
Zantab (Israel)
Zantadin (Indonesia)
Zantic (Germany; Switzerland)
Zinetac (India)
COST OF THERAPY: $99.12 (Duodenal Ulcer; Zantac Tablet;
150 mg; 2/day; 28 days)